Harbour BioMed Company
Harbour BioMed (HKEX: 02142.HK) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on oncology and immunology.
Headquarters:
China
Founded Date:
2016
Employee Number:
51-100
Technology:
Others
Funding Status:
Late Stage Venture
Estimated Revenue:
$10M to $50M
Industry:
Loss of Proteostasis